Autopsy report · NCT04230746
Effect of Antibiotics on Urinary Microbiome
Cause of deathFunding or business, also slow enrollment
“funding , recruitment issues”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Early Phase 1
- Sponsor
- Johns Hopkins University
- Sponsor type
- University, hospital or other
- Conditions
- Microtia; UTI; Bacteriuria; Antibiotic Resistant Infection; Antibiotics Causing Adverse Effects in Therapeutic Use
- Interventions
- Bactrim DS 800Mg-160Mg Tablet; Placebo oral tablet
- Participants
- 0
Trials that died the same way
- Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)
“Recruitment and funding challenges” - Slow and Deep Breathing to Lower Blood Pressure in Women With Pregnancy-induced Hypertension
“Funding and recruitment” - Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression
“Difficulty in recruitment and funding.” - Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
“insufficient funding and recruitment” - Perineal Local Infiltration Study
“Recruitment issues”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.